Food News and Research

RSS

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Orexo AB today announces that ProStrakan's partner, Paladin Labs Inc. has been informed by Health Canada, the Canadian Government Department with responsibility for public health, that it has approved Abstral.

22 Feb 2011

FDA clears ArthroCare's Parallax Contour-enhanced Vertebral Augmentation Device

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.

22 Feb 2011

FDA approves OraSure's rapid antibody test to detect HCV

OraSure Technologies, Inc. announced today that its OraQuick HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug Administration for use in detecting HCV antibodies with a fingerstick whole blood sample.

22 Feb 2011

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

22 Feb 2011

Radiologists who interpret more mammograms can determine breast cancer effectively

Radiologists who interpret more mammograms and spend some time reading diagnostic mammograms do better at determining which suspicious breast lesions are cancer, according to a new report published online on February 22 and in print in the April issue of Radiology.

22 Feb 2011

Researchers identify practical strategies to implement environmental practices in operating rooms

Johns Hopkins researchers say they have identified practical strategies to implement environmentally friendly practices in operating rooms and other hospital facilities that could result in vastly reduced health care costs and pose no risk to patient safety.

22 Feb 2011

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Fate Therapeutics, Inc. presented encouraging preliminary data from an ongoing Phase 1b clinical trial of FT1050 at the 2011 BMT Tandem Meetings in Honolulu, Hawaii.

22 Feb 2011

Pharming, Santarus begin RHUCIN Phase IIIb study in patients with Hereditary Angioedema

Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV (NYSE Euronext: PHARM) today announced that Pharming has begun an international, multicenter, randomized, placebo-controlled Phase IIIb clinical study evaluating the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema.

22 Feb 2011

New research: Fluid retention may explain drugs' risk of strokes and heart attacks

New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration if the cardiovascular effects of fluid retention had been better understood. Fluid retention may explain the increased risk of heart attacks and strokes of medications such as Vioxx, Bextra, and Avandia.

22 Feb 2011

U.S. House approves bill cuts for older Americans

Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.

22 Feb 2011

Investigational heart valve implanted in patient through small puncture hole in leg

Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.

21 Feb 2011

Lifestyle therapy program may help manage cardiovascular risk factors

Two/thirds of adults with high cholesterol and half with high blood pressure are not being treated effectively for these conditions, according to a recent announcement by the Centers for Disease Control and Prevention (CDC). This disturbing data spotlights the crucial need for new solutions to reduce the risk factors that are behind the current epidemic of chronic illness in the U.S.

21 Feb 2011

Cedars-Sinai, AirStrip enter mobile patient monitoring solution collaboration

Cedars-Sinai Medical Center and AirStrip Technologies announced a developmental collaboration to leverage mobile patient monitoring in a variety of clinical environments where immediate access to data is necessary. A key goal of the partnership will be to develop, deploy, and create innovative ways to get real-time device data available anytime and anywhere.

21 Feb 2011

EUFIC, University of Surrey publish European nutrition labelling consumer research results

The European Food Information Council, in collaboration with researchers at the University of Surrey, UK, has published the results of its latest European nutrition labelling consumer research - now focusing on portion information.

21 Feb 2011

Oral sex linked to cancer

Researchers from the United States have said that there is strong evidence linking oral sex to cancer. They have urged more study of how human papillomaviruses may be to blame for a rise in oral cancer among white men.

20 Feb 2011

QRxPharma granted FDA pre-NDA meeting, further phase II data released

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the granting of a pre-New Drug Application (NDA) meeting with the United States Food and Drug Administration (FDA) and successful completion of its third pivotal Phase 3 registration trial (study 009) for immediate-release MoxDuo.

20 Feb 2011

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Protalix BioTherapeutics, Inc., announced today that new clinical data from the switchover trial of taliglucerase alfa in Gaucher disease patients and preclinical data on oral enzyme glucocerebrosidase (oral GCD) will be presented today at the 7th Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2011 in Las Vegas, Nevada.

19 Feb 2011

Eating tissue to stay thin

In a recent interview on CNN, Janet Jackson talks about the extreme measures some women in Hollywood take to achieve and maintain a thin body. She says some are even eating Kleenex to stay full so they don't feel hungry. Kimberly Dennis, M.D., and Medical Director at Timberline Knolls Residential Treatment Center, a residential treatment center for eating disorders and addictions, warns about the dangers of this behavior, and says there might be deeper problems hidden below the surface.

19 Feb 2011

FDA recognizes safety and efficacy of True Results LAP-BAND device

The True Results team of gastric band surgeons and medical weight loss experts is pleased the U.S. Food and Drug Administration has recognized the long-standing safety and effectiveness record of the LAP-BAND System.

19 Feb 2011

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Australian health care company Prima BioMed Ltd announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.

19 Feb 2011

Food News and Research

Health Canada approves Orexo's Abstral to treat chronic cancer pain

FDA clears ArthroCare's Parallax Contour-enhanced Vertebral Augmentation Device

FDA approves OraSure's rapid antibody test to detect HCV

FDA refuses Delcath's chemosaturation delivery system NDA filing

Radiologists who interpret more mammograms can determine breast cancer effectively

Researchers identify practical strategies to implement environmental practices in operating rooms

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Pharming, Santarus begin RHUCIN Phase IIIb study in patients with Hereditary Angioedema

New research: Fluid retention may explain drugs' risk of strokes and heart attacks

U.S. House approves bill cuts for older Americans

Investigational heart valve implanted in patient through small puncture hole in leg

Lifestyle therapy program may help manage cardiovascular risk factors

Cedars-Sinai, AirStrip enter mobile patient monitoring solution collaboration

EUFIC, University of Surrey publish European nutrition labelling consumer research results

Oral sex linked to cancer

QRxPharma granted FDA pre-NDA meeting, further phase II data released

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Eating tissue to stay thin

FDA recognizes safety and efficacy of True Results LAP-BAND device

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Enhancing confidence in chemical ionization spectrometry data eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News